Trials / Conditions / Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

9 registered clinical trials studyying Precursor B-Cell Lymphoblastic Leukemia-Lymphoma — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Nanobody-Based CD19/CD22 Tandem Dual CAR-T Therapy for R/R B-ALL NCT06880913	Peking University People's Hospital	Phase 1 / Phase 2
Completed	A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eli NCT03677596	Pfizer	Phase 4
Completed	A Safety Study of SGN-CD19A for B-Cell Lymphoma NCT01786135	Seagen Inc.	Phase 1
Completed	A Safety Study of SGN-CD19A for Leukemia and Lymphoma NCT01786096	Seagen Inc.	Phase 1
Completed	Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia NCT01116193	Institut de Cancérologie de la Loire	Phase 2
Terminated	Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia NCT00905398	Rony Schaffel	Phase 1 / Phase 2
Completed	Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604) NCT00864227	Medical College of Wisconsin	Phase 2
Completed	Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT NCT00849147	Medical College of Wisconsin	Phase 2
Completed	Coproporphyrine Isomers and Methotrexate Elimination NCT00822432	Assistance Publique - Hôpitaux de Paris	—